Cargando…
The MOLES System for Planning Management of Melanocytic Choroidal Tumors: Is It Safe?
Purpose: To evaluate the MOLES system for identifying malignancy in melanocytic choroidal tumors in patients treated for choroidal melanoma. Methods: Records of 615 patients treated for choroidal melanoma between January 2017 and December 2019 were reviewed. Patients were excluded if iris and/or cil...
Autores principales: | Roelofs, Kelsey A., O’Day, Roderick, Al Harby, Lamis, Arora, Amit K., Cohen, Victoria M.L., Sagoo, Mandeep S., Damato, Bertil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281649/ https://www.ncbi.nlm.nih.gov/pubmed/32455720 http://dx.doi.org/10.3390/cancers12051311 |
Ejemplares similares
-
Detecting Progression of Melanocytic Choroidal Tumors by Sequential Imaging: Is Ultrasonography Necessary?
por: Roelofs, Kelsey A., et al.
Publicado: (2020) -
Reply to Comment on Roelofs, K.A.; et al. “Detecting Progression of Melanocytic Choroidal Tumours by Sequential Imaging: Is Ultrasonography Necessary?” Cancers 2020, 12, 1856
por: Roelofs, Kelsey A., et al.
Publicado: (2021) -
Can the MOLES acronym and scoring system improve the management of patients with melanocytic choroidal tumours?
por: Damato, Bertil E.
Publicado: (2022) -
Detecting Progression of Treated Choroidal Melanomas: Is Ultrasonography Necessary?
por: Negretti, Guy S., et al.
Publicado: (2021) -
Visual Loss from Choroidal Melanoma Mimicking Neurological Syndromes
por: Hammamji, Karim, et al.
Publicado: (2017)